UFP Technologies, Inc.
UFPTHealthcareNASDAQMedical Devices · Last scanned Jun 3, 2026
Scan Results
Daily timeframeUFP Technologies, Inc., together with its subsidiaries, designs and manufactures solutions for medical devices, sterile packaging, and other engineered custom products in the United States. The company carries a $1.67B market cap, placing it firmly in the small-cap category. The company provides protective drapes for robotic surgery, patient handling and comfort, advanced wound care, infection prevention, disposables for surgical and endoscopic procedures, packaging for medical devices, orthopedic implants, components for cardiac implants, dispenser coils for catheters, and biopharma drug manufacturing.
Market Cap
$1.67B
Beta
1.08
P/E (TTM)
24.64
P/E (Fwd)
18.51
EPS (TTM)
$8.78
EPS (Fwd)
$11.69
ROE
17.2%
ROA
8.8%
Cash
$20.0M
Total Debt
$156.1M
Free CF
$53.6M
52W Change
-9.9%
Annual Financials
Cash vs Debt
UFP Technologies, Inc. carries $156.1M in total debt against $20.0M in cash reserves — debt is roughly 7.8x the cash position. Managing this leverage effectively will be important for long-term financial stability. Free cash flow comes in at $53.6M, providing flexibility for reinvestment, buybacks, or dividends. Consistent free cash flow generation is often considered a sign of operational health. ROE of 17.2% points to strong capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. An ROA of 8.8% suggests reasonable efficiency in deploying the company's asset base. Revenue has grown from $353.8M (2022) to $602.8M (2025), reflecting a 70% increase over the period.
Debt significantly exceeds cash reserves, which means the company's financial flexibility could be constrained during economic downturns. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing UFPT.